Teva Pharmaceuticals, makers of a patch called Zecuity marketed for migraine relief, are pulling it from shelves after users reported burns and scarring, reports Mary Beth Quirk of Consumerist.
The U.S. Food & Drug Administration announced that Teva will temporarily suspend sales, marketing and distribution of the product to investigate the cause of burns. According to Quirk, the company says it’s working with the FDA to examine adverse skin reactions connected to using the product.
According to the Zecuity web site, patients are advised to discontinue the use of the patch and discuss alternative treatment options with their physicians. Zecuitiy is a disposable, battery-powered patch patients stick on their upper arm or thigh for relief from migraines.